new glp 1 agonist In the ATTAIN-1 phase 3, randomized trial, the use of orforglipron Could GLP-1 Receptor Agonists Help
Description
Microglia function in the central nervous system during health and neurodegeneration
GLP-1RAs have been shown to reduce the levels of systemic inflammatory markers
Increased serum resistin levels in patients with type 2 diabetes are not linked with markers of insulin resistance and adiposity
[38] suggested that obese patients treated with liraglutide or Semaglutide showed a marked reduction in self-reported alcohol intake after 36 months, particularly among high consumers
Time above the therapeutic INR range increased significantly after GLP-1 RA initiation, while time below range showed a numerical increase
